Bandingkan Harga & Kinerja Humpuss Maritim Internasional Tbk. (HUMI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Humpuss Maritim Internasional Tbk. dan Organon Pharma Indonesia Tbk.: Humpuss Maritim Internasional Tbk. diperdagangkan di Rp137 (kapitalisasi pasar 2,47 T, volume 24 jam 40,18 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Humpuss Maritim Internasional Tbk. jauh lebih besar — sekitar 23,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HUMI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,47 T | 104,4 M |
Volume | 40,18 jt | — |
Lot | 401,82 rb | — |
Perputaran | 5,4 M | — |
Harga Rata-rata | 134,5 | — |
Nilai Transaksi | 5,4 M | — |
Harga Ekuilibrium Indikatif | 137 | — |
Volume Ekuilibrium Indikatif | 13,29 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Humpuss Maritim Internasional Tbk.
PT Humpuss Maritim Internasional Tbk. (the Company) is a limited liability company incorporated under the laws of the Republic of Indonesia by virtue of Notarial Deed No. 21 dated September 29, 2016 of Martina, S.H., Notary in Jakarta. The Company change its name from PT MISI Hutama Internasional to PT Humpuss Maritim Internasional. The Company has started its commercial operation since December 2016. Parent entity ofthe Company is PT Humpuss Transportasi Kimia and ultimate parent of the Company is PT Humpuss Intermoda Transportasi Tbk. The Company’s controlling party is H. Hutomo Mandala Putra, SH.
Selengkapnya di halaman HUMI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
